Prognostic value of neutrophil-to-lymphocyte ratio in mCRPC patients treated with abiraterone, enzalutamide and docetaxel: a retrospective single-center study. Archivio Italiano di Urologia e Andrologia, [S. l.], 2026. DOI: 10.4081/aiua.2026.15630. Disponível em: https://www.pagepressjournals.org/aiua/article/view/15630. Acesso em: 12 aug. 2026.